Category Archives: Pharmaceuticals

New Type of Non-Opioid Pain Drug Seeks FDA Approval

ELI LILLY & CO. (Indianapolis IN) said it and partner Pfizer Inc. (New York City) aim to seek approval by 2018 for a new type of pain drug that could… Read more »

FDA Approves New Treatment for Opioid Addiction

Federal health officials on Thursday approved an innovative new option for Americans struggling with addiction to heroin and painkillers: a drug-oozing implant that curbs craving and withdrawal symptoms for six… Read more »

Cigna Signs “Results-Based” Deals on Costly Amgen, Sanofi Cholesterol Meds

Cigna Corp. (Bloomfield CT) signed deals that will pay the makers of two potent but pricey cholesterol-lowering treatments based on how well their customers respond to the medications, the health… Read more »

AbbVie Agrees to Buy Stemcentrx, Reports Jump in Earnings

U.S. biopharmaceutical firm AbbVie Inc. (North Chicago) on Thursday said it will acquire cancer biotech company Stemcentrx Inc. (South San Francisco) in a roughly $5.8 billion cash and stock deal that would expand… Read more »

New AbbVie Hepatitis C Regimen Shows Strong Cure Rates

Although arriving a little late to the party, AbbVie Inc. (North Chicago) is touting impressive cure rates for its new daily hep C combo as it looks to find a… Read more »

U.S. Prescription Spending to Pass $610 Billion a Year by 2020 Says IMS Health

Spending on prescription drugs in the U.S. rose 12% to a record $425 billion before discounts last year, boosted in part by the introduction of breakthrough medicines for cancer and… Read more »

Price of Insulin Rose Nearly 200% Between 2002 and 2013

The cost of the hormone insulin, one of the most important treatments for diabetes, rose nearly 200% between 2002 and 2013, according to a new study. While other diabetes medications… Read more »